Privia Health Group, Inc.
PRVA Healthcare Health Information Services
Privia Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 22.3% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +83.3%
- Free cash flow
- −44.4%
Quarter to September 2026, against a year earlier
Follow PRVA
Alert me
Privia Health Group, Inc. (PRVA) P/B ratio
As of 5 November 2026, Privia Health Group, Inc. (PRVA) trades at a P/B ratio of 3.5×. Over the past ten years it has ranged from 2.9× (September 2026) to 31.6× (June 2021); the current reading is higher than 17% of that period. That is above the Health Information Services industry median of 1.9× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 3.7× | 7.23% |
| FY2024 | 3.4× | (25.04%) |
| FY2023 | 4.6× | (4.14%) |
| FY2022 | 4.8× | (19.65%) |
| FY2021 | 5.9× | (59.97%) |
| FY2020 | 14.8× | 0.00% |
| FY2019 | 14.8× | 0.00% |
| FY2018 | 14.8× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 2.9× | (25.70%) |
| Jun 2026 | 3.9× | 22.19% |
| Mar 2026 | 3.2× | (13.48%) |
| Dec 2025 | 3.7× | (8.61%) |
| 23 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| TDOC Teladoc Health, Inc. compare | 1.3× |
| OMCL Omnicell, Inc. compare | 1.3× |
| WAY Waystar Holding Corp. compare | 1.4× |
| GDRX GoodRx Holdings, Inc. compare | 1.8× |
| CERT Certara, Inc. compare | 1.9× |
| PRVA Privia Health Group, Inc. | 3.5× |
| DOCS Doximity, Inc. compare | 6.4× |
| SDGR Schrodinger, Inc. compare | 7.2× |
| HTFL Heartflow, Inc. compare | 16.1× |
| Health Information Services industry median | 1.9× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on PRVA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement